Clinical Features of Patients with Cervical Cancer Treated by Surgery
1.Department of Obstetrics and Gynecology,the First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China
2.Office of Medical Information Management,the First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China
*Corresponding author:AN Ruifang,Chief physician,Doctoral supervisor;E-Mail:anruifang@163.com
[1]FERLAY J,SOERJOMATARAM I,DIKSHIT R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):e359-386.DOI:10.1002/ijc.29210.
[2]LI J X,DONG L,LI L,et al.Research progression on triage of human papillomavirus positive women[J].Zhonghua Zhong Liu Za Zhi,2018,40(9):641-646.DOI:10.3760/cma.j.issn.0253-3766.2018.09.001.
[3]PEDERSEN K,FOGELBERG S,THAMSBORG L H,et al.An overview of cervical cancer epidemiology and prevention in Scandinavia[J].Acta Obstet Gynecol Scand,2018,97(7):795-807.DOI:10.1111/aogs.13313.
[4]EBINA Y,MIKAMI M,NAGASE S,et al.Japan society of gynecologic oncology guidelines 2017 for the treatment of uterine cervical cancer[J].Int J Clin Oncol,2019,24(1):1-19.DOI:10.1007/s10147-018-1351-y.
[5]ISHIKAWA M,NAKAMURA K,SHIBATA T,et al.A randomized phaseⅡ/Ⅲ trial of conventional paclitaxel and carboplatin with or without bevacizumab vs dose-dense paclitaxel and carboplatin with or without bevacizumab,in stage ⅣB,recurrent or persistent cervical carcinoma:Japan Clinical Oncology Group Study(JCOG1311)[J].Jpn J Clin Oncol,2018,42(12):1096-1100.DOI:10.1093/jjco/hyy137.
[6]陈琰,范江涛,陈思邦,等.达芬奇机器人手术治疗早期宫颈癌的学习曲线[J].中国妇幼保健,2019,34(15):3610-3613.DOI:10.7620/zgfybj.j.issn.1001-4411.2019.15.70.
[7]李军,薛海鲸,冯玲霞,等.陕西省宝鸡地区妇女人群HPV-DNA亚型分析[J].现代肿瘤医学,2017,25(22):3674-3679.DOI:10.3969/j.issn.1672-4992.2017.22.032.
LI J,XUE H Q,FENG L X,et al.Analysis of HPV-DNA infection status and its subtype distribution of women in Baoji, China[J].Journal of Modern Oncology,2017,25(22):3674-3679.DOI:10.3969/j.issn.1672-4992.2017.22.032.
[8]李军,张碧莹,王一羽,等.陕西省铜川地区妇女人群HPV感染现状及其常见亚型流行特征[J].解放军预防医学杂志,2017,35(12):1511-1514.
[9]李丽,杨亚玲,闫翠起,等.陕西地区宫颈病变患者HR-HPV感染的流行病学调查及与宫颈病变的相关性分析[J].解放军预防医学杂志,2018,36(9):1197-1199.
[10]王艳花,郭改利,王彩梅.陕西汉中地区2 070例女性高危型HPV感染及危险因素[J].公共卫生与预防医学,2019,30(3):62-66.DOI:10.3969/j.issn.1006-2483.2019.03.014.
[11]詹雪梅,李明伟,房昭,等.腹腔镜和开腹手术治疗914例宫颈癌近/远期效果及安全性分析[J].中华肿瘤防治杂志,2019,26(16):1213-1217.DOI:10.16073/j.cnki.cjcpt.2019.16.12.
[12]张慧琦,陈群.宫颈癌前病变和宫颈癌高危型HPV分布特点[J].医学临床研究,2019,36(9):1841-1843.DOI:10.3969/j.issn.1671-7171.2019.09.065.
[13]KOH W J,ABU-RUSTUM N R,BEAN S,et al.Uterine neoplasms,version 1 2018,nccn clinical practice guidelines in oncology[J].J Natl Compr Canc Netw,2018,16(2):170-199.DOI:10.6004/jnccn.2018.0006.
[14]朱丽娟,周树林,江希萍.重组人干扰素α2b联合洁悠神对宫颈持续HPV感染患者端粒酶与HPV16/18 E6蛋白表达的影响[J].中国现代医学杂志,2017,27(25):23-27.DOI:10.3969/j.issn.1005-8982.2017.25.005.
[15]EL-ZEIN M,RICHARDSON L,FRANCO E L.Cervical cancer screening of HPV vaccinated populations:cytology,molecular testing,both or none[J].J Clin Virol,2016,76(suppl 1):s62-68.DOI:10.1016/j.jcv.2015.11.020.
[16]汪元元,张帆.青年及中老年宫颈癌患者临床特征对比分析[J].安徽医药,2018,22(5):853-856.DOI:10.3969/j.issn.1009-6469.2018.05.015.
[17]HANPRASERTPONG J,JIAMSET I,ATJIMAKUL T.Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection[J].Tumour Biol,2016,37(6):7421-7430.DOI:10.1007/s13277-015-4626-1.
[18]ALKAN A,YAZICI G,CENGIZ M,et al.The role of ABO blood groups in glial neoplasms[J].Br J Neurosurg,2019,33(1):43-46.DOI:10.1080/02688697.2018.1522415.
[19]WOLPIN B M,KRAFT P,GROSS M,et al.Pancreatic cancer risk and ABO blood group alleles:results from the pancreatic cancer cohort consortium[J].Cancer Research,2010,70(3):1015-1023.DOI:10.1158/0008-5472.CAN-09-2993.
[20]YUZHALIN A E,KUTIKHIN A G.ABO and Rh blood groups in relation to ovarian,endometrial and cervical cancer risk among the population of South-East Siberia[J].Asian Pac J Cancer Prev,2012,13(10):5091-5096.DOI:10.7314/apjcp.2012.13.10.5091.